Boothbay Fund Management, LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Boothbay Fund Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$8.95 - $11.35 $24,093 - $30,554	2,692 Added 9.58%	30,790 $296,000
Q1 2023 May 15, 2023	BUY	$6.3 - $8.39 $177,017 - $235,742	28,098 New	28,098 $220,000
Q4 2021 Feb 14, 2022	SELL	$12.36 - $18.28 $173,484 - $256,578	-14,036 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$17.11 - $24.49 $48,250 - $69,061	-2,820 Reduced 16.73%	14,036 $245,000
Q2 2021 Aug 16, 2021	SELL	$23.12 - $29.91 $370,359 - $479,128	-16,019 Reduced 48.73%	16,856 $404,000
Q1 2021 May 17, 2021	SELL	$14.69 - $42.57 $1.18 Million - $3.43 Million	-80,658 Reduced 71.04%	32,875 $845,000
Q4 2020 Feb 12, 2021	SELL	$12.88 - $19.47 $235,562 - $356,086	-18,289 Reduced 13.87%	113,533 $2.16 Million
Q3 2020 Nov 16, 2020	BUY	$9.83 - $13.99 $68,023 - $96,810	6,920 Added 5.54%	131,822 $1.66 Million
Q2 2020 Aug 14, 2020	BUY	$6.75 - $12.89 $110,767 - $211,524	16,410 Added 15.13%	124,902 $1.51 Million
Q1 2020 May 15, 2020	BUY	$5.8 - $18.56 $375,509 - $1.2 Million	64,743 Added 147.99%	108,492 $830,000
Q4 2019 Feb 14, 2020	BUY	$10.31 - $17.81 $143,556 - $247,986	13,924 Added 46.69%	43,749 $779,000
Q3 2019 Nov 14, 2019	BUY	$11.6 - $21.67 $345,970 - $646,307	29,825 New	29,825 $346,000
Q4 2017 Feb 14, 2018	SELL	$6.8 - $13.54 $147,322 - $293,344	-21,665 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$5.84 - $8.88 $126,523 - $192,385	21,665	21,665 $146,000

135

52M

551K

98K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $240M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.